Maze CEO Jason V. Coloma sells shares worth about $593K
Maze Therapeutics CEO Jason V. Coloma reported sales of common stock to satisfy tax withholding on vested restricted stock units, executed at weighted average prices of $26.376, $27.1211 and $26.0133 per share.
Jason V.
Coloma, a Director and Chief Executive Officer, reported sales of Maze Therapeutics common stock to satisfy tax withholding on vested restricted stock units.
The transactions were executed at weighted average prices of $26.376, $27.1211 and $26.0133 per share (multiple transactions within…